Fundz

Cellarity Appoints Christopher Woelk, Ph.D. as Vice President and Head of Platform

PRIVATEMay 07, 2024

Company

Cellarity

SomervilleBiotechnologyHealth CareTherapeutics

Description

Cellarity announced the appointment of Christopher (“Topher”) Woelk, Ph.D., as Vice President and Head of Platform. In this role, Woelk will lead Cellarity’s revolutionary platform to create drugs that are presently out of reach with traditional methods of drug discovery.

Quick answer

Cellarity Appoints Christopher Woelk, Ph.D. as Vice President and Head of Platform (May 7, 2024). Cellarity is based in Somerville, Massachusetts, United States.

What did Cellarity announce on May 7, 2024?
Cellarity announced the appointment of Christopher (“Topher”) Woelk, Ph.D., as Vice President and Head of Platform. In this role, Woelk will lead Cellarity’s revolutionary platform to create drugs that are presently out of reach with traditional methods of drug discovery.
What does Cellarity do?
Cellarity is fundamentally redesigning the way drugs are created.
Where is Cellarity based?
Cellarity is based in Somerville, Massachusetts, United States.

Source: Fundz verified event record.

Who to call at Cellarity, and when

A new leader at Cellarity brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Cellarity raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cellarity, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cellarity. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cellarity

Location

Somerville, Massachusetts, United States

About

Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas including those in metabolic disease, hematology, and immuno-oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cellarity changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ted
Likely contact at this company
••••••••@••••••••

See Ted's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Cellarity's next move

Learn about Strategic plan

Cellarity changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.